Home > Insider Trading > Filing (0001593968-21-002357)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1771917	Karuna Therapeutics Inc.	KRTX	Pharmaceutical Preparations (2834)	270605902

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777760	Craig Andrew Miller	C/O Karuna Therapeutics, Inc. 99 High Street, 26Th Floor Boston MA 02110	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-02	26,500	$2.92	54,327	No	4	M	Direct
Common Stock	Disposition	2021-11-01	100	$136.67	54,227	No	4	S	Direct
Common Stock	Disposition	2021-11-01	500	$139.87	53,727	No	4	S	Direct
Common Stock	Disposition	2021-11-01	400	$140.74	53,327	No	4	S	Direct
Common Stock	Disposition	2021-11-01	787	$142.14	52,540	No	4	S	Direct
Common Stock	Disposition	2021-11-01	740	$143.78	51,800	No	4	S	Direct
Common Stock	Disposition	2021-11-01	300	$144.54	51,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2021-11-02	26,500	$0.00	26,500	$2.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,417		2026-10-11	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.48 to $140.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (6) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.55 to $141.18, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.93 to $142.85, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.35 to $144.24, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.46 to $144.67, inclusive.
This option vested as to 1/16th of the shares underlying the option award on the vesting commencement date of July 18, 2016 and as to an additional 1/16th of the shares on each three month anniversary thereafter.